Publications by authors named "Rory Rebuck"

Claim this Profile
A
A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn's Disease.
Matthieu Allez, Bruce E Sands, Brian G Feagan, Geert D'Haens, Gert De Hertogh, Rory Rebuck

J Crohns Colitis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn's Disease: The IM-UNITI Trial.
William J Sandborn, Rory Rebuck, Yuhua Wang, Bin Zou, Omoniyi J Adedokun

Clin Gastroenterol Hepatol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis